Pattern play: Abiomed
Jason Lubin December 31, 2020 4:10 PM
Price is holding near a new 52-week high after an upside breakout from a bull flag.
Abiomed (ABMD), a developer of medical devices for cardiovascular conditions, is currently holding around a new 52-week high after breaking out to the upside of an intermediate-term bull flag in mid-December. The RSI is currently in overbought territory at 76. The simple moving averages (SMAs) just turned bullish, as the 20-day SMA just crossed to the upside of the 50-day SMA and the 50-day SMA is above the 200-day SMA. The overbought reading on the RSI could be hinting at a price consolidation. If price can manage to stay above 293.00, then its next targets would be 364.00 and 391.00. On the other hand, if price slips below 293.00, it would be a bearish signal that could send price back to 254.00. If price cannot manage to rebound off of 254.00 then it could be the beginning of a new downtrend.
Source: GAIN Capital, TradingView
StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.